GlassScriptPhysician profile
Ovidio J Falcone
NPI 1477555415
$22,873.49
in general payments reported to CMS, 2019-2025
24 companies · $4,729 in 2025
The $4,729 reported for 2025 was more than what 93% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,575 · 2020: $1,389 · 2021: $4,015 · 2022: $3,598 · 2023: $3,800 · 2024: $2,768 · 2025: $4,729.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $11K · Travel and Lodging: $4.72.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $11,292.02 |
| Travel and Lodging | $4.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $18,757.85 | 2019-2025 | Prostep Mica, Vitoss, Hoffmann |
| Royal Biologics, INC. | $1,113.26 | 2019-2022 | |
| Smith+Nephew, INC. | $382.57 | 2019-2024 | Grafix Pl, Collagenase Santyl |
| Polynovo North America LLC | $379.22 | 2025 | Novosorb Btm |
| Paratek Pharmaceuticals, INC. | $321.04 | 2021-2024 | Nuzyra |
| Acumed LLC | $309.03 | 2022-2025 | Acumed, Acumed |
| Melinta Therapeutics, LLC | $177.77 | 2021 | |
| Aroa Biosurgery Incorporated | $176.55 | 2025 | |
| Mimedx Group, INC. | $172.70 | 2025 | |
| Osteomed LLC | $164.16 | 2021 | |
| Organogenesis INC. | $130.75 | 2019 | |
| Amniox Medical, INC. | $102.69 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $96.12 | 2024-2025 | |
| Abbvie INC. | $93.07 | 2022 | |
| Paragon 28, INC. | $82.48 | 2020-2021 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $78.74 | 2022-2024 | |
| Biocomposites INC | $65.13 | 2021 | |
| Fidia Pharma USA INC. | $54.35 | 2020-2025 | Hyalgan, Triluron, Hymovis |
| Orthofix Medical, INC. | $51.75 | 2025 | Physio-Stim |
| Integra Lifesciences Corporation | $46.78 | 2019 | |
| Avanos Medical | $37.67 | 2025 | Standard Rf Disposables |
| Hydrofera LLC | $32.22 | 2023 | Hydrofera Blue |
| Voom Medical Devices, INC. | $30.71 | 2024 | Revcon |
| Axogen | $16.88 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ovidio Falcone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.